208 related articles for article (PubMed ID: 33398644)
1. Neoadjuvant Chemotherapy for Pancreatic Ductal Adenocarcinoma is Associated with Lower Post-Pancreatectomy Readmission Rates: A Population-Based Cohort Study.
Kamarajah SK; Naffouje SA; Salti GI; Dahdaleh FS
Ann Surg Oncol; 2021 Apr; 28(4):1896-1905. PubMed ID: 33398644
[TBL] [Abstract][Full Text] [Related]
2. Adjuvant Chemotherapy Associated with Survival Benefit Following Neoadjuvant Chemotherapy and Pancreatectomy for Pancreatic Ductal Adenocarcinoma: A Population-Based Cohort Study.
Kamarajah SK; White SA; Naffouje SA; Salti GI; Dahdaleh F
Ann Surg Oncol; 2021 Oct; 28(11):6790-6802. PubMed ID: 33786676
[TBL] [Abstract][Full Text] [Related]
3. Impact of Neoadjuvant Systemic Therapy on Pancreatic Fistula Rates Following Pancreatectomy: a Population-Based Propensity-Matched Analysis.
Dahdaleh FS; Naffouje SA; Hanna MH; Salti GI
J Gastrointest Surg; 2021 Mar; 25(3):747-756. PubMed ID: 32253648
[TBL] [Abstract][Full Text] [Related]
4. Laparoscopic versus open pancreatic resection for ductal adenocarcinoma: separate propensity score matching analyses of distal pancreatectomy and pancreaticoduodenectomy.
Chen K; Pan Y; Huang CJ; Chen QL; Zhang RC; Zhang MZ; Wang GY; Wang XF; Mou YP; Yan JF
BMC Cancer; 2021 Apr; 21(1):382. PubMed ID: 33836678
[TBL] [Abstract][Full Text] [Related]
5. Neoadjuvant Therapy for Pancreatic Ductal Adenocarcinoma: Propensity-Matched Analysis of Postoperative Complications Using ACS-NSQIP.
Krell RW; McNeil LR; Yanala UR; Are C; Reames BN
Ann Surg Oncol; 2021 Jul; 28(7):3810-3822. PubMed ID: 33386542
[TBL] [Abstract][Full Text] [Related]
6. Effect and limitation of neoadjuvant chemotherapy for pancreatic ductal adenocarcinoma: consideration from a new perspective.
Kurata Y; Shiraki T; Ichinose M; Kubota K; Imai Y
World J Surg Oncol; 2021 Mar; 19(1):85. PubMed ID: 33752677
[TBL] [Abstract][Full Text] [Related]
7. Modified Appleby Procedure for Pancreatic Adenocarcinoma: Does Improved Neoadjuvant Therapy Warrant Such an Aggressive Approach?
Peters NA; Javed AA; Cameron JL; Makary MA; Hirose K; Pawlik TM; He J; Wolfgang CL; Weiss MJ
Ann Surg Oncol; 2016 Oct; 23(11):3757-3764. PubMed ID: 27328946
[TBL] [Abstract][Full Text] [Related]
8. Survival benefit of neoadjuvant therapy in patients with non-metastatic pancreatic ductal adenocarcinoma: A propensity matching and intention-to-treat analysis.
Sugimoto M; Takahashi N; Farnell MB; Smyrk TC; Truty MJ; Nagorney DM; Smoot RL; Chari ST; Carter RE; Kendrick ML
J Surg Oncol; 2019 Nov; 120(6):976-984. PubMed ID: 31452208
[TBL] [Abstract][Full Text] [Related]
9. Association of Adjuvant Chemotherapy in Patients With Resected Pancreatic Adenocarcinoma After Multiagent Neoadjuvant Chemotherapy.
Sugawara T; Rodriguez Franco S; Sherman S; Kirsch MJ; Colborn K; Ishida J; Grandi S; Al-Musawi MH; Gleisner A; Schulick RD; Del Chiaro M
JAMA Oncol; 2023 Mar; 9(3):316-323. PubMed ID: 36480190
[TBL] [Abstract][Full Text] [Related]
10. Laparoscopic versus open distal pancreatectomy for pancreatic ductal adenocarcinoma: a single-center propensity score matching study.
Chen K; Tong Q; Yan JF; Huang CJ; Pan Y; Zhang RC; Chen QL; Zheng XY; Cai XY; Wang Y; Wang XF
Updates Surg; 2020 Jun; 72(2):387-397. PubMed ID: 32266660
[TBL] [Abstract][Full Text] [Related]
11. Survival benefit and impact of adjuvant chemotherapy following systemic neoadjuvant chemotherapy in patients with resected pancreas ductal adenocarcinoma: a retrospective cohort study.
Pu N; Wu W; Liu S; Xie Y; Yin H; Chen Q; He T; Xu Z; Wang W; Yu J; Liu L; Lou W
Int J Surg; 2023 Oct; 109(10):3137-3146. PubMed ID: 37418574
[TBL] [Abstract][Full Text] [Related]
12. The prognostic influence of intrapancreatic tumor location on survival after resection of pancreatic ductal adenocarcinoma.
Ruess DA; Makowiec F; Chikhladze S; Sick O; Riediger H; Hopt UT; Wittel UA
BMC Surg; 2015 Nov; 15():123. PubMed ID: 26615588
[TBL] [Abstract][Full Text] [Related]
13. Survival outcomes of neoadjuvant therapy followed by radical resection versus upfront surgery for stage I-III pancreatic ductal adenocarcinoma: a retrospective cohort study.
Zou Y; Gao S; Yu X; Zhou T; Xie Y; Guo X; An R; Wang X; Zhao T; Chang A; Gao C; Yu J; Hao J
Int J Surg; 2023 Jun; 109(6):1573-1583. PubMed ID: 37132194
[TBL] [Abstract][Full Text] [Related]
14. Weight loss during neoadjuvant chemotherapy impacts perioperative outcomes in patients undergoing surgery for pancreatic cancer.
Doshi S; Abad J; Wells A; Chawla A
Pancreatology; 2023 Dec; 23(8):1020-1027. PubMed ID: 37926598
[TBL] [Abstract][Full Text] [Related]
15. Extensive (subtotal) distal pancreatectomy for pancreatic ductal adenocarcinoma: a propensity score matched cohort study of short- and long-term outcomes compared with those of conventional distal pancreatectomy.
Watanabe Y; Nakata K; Mori Y; Ideno N; Ikenaga N; Ohtsuka T; Nakamura M
Langenbecks Arch Surg; 2022 Jun; 407(4):1479-1488. PubMed ID: 35146547
[TBL] [Abstract][Full Text] [Related]
16. Does a Laparoscopic Approach to Distal Pancreatectomy for Cancer Contribute to Optimal Adjuvant Chemotherapy Utilization?
Salehi O; Vega EA; Kutlu OC; Krishnan S; Sleeman D; De La Cruz Munoz N; Alarcon SV; Kazakova V; Kozyreva O; Conrad C
Ann Surg Oncol; 2021 Dec; 28(13):8273-8280. PubMed ID: 34125349
[TBL] [Abstract][Full Text] [Related]
17. Minimally Invasive versus Open Distal Pancreatectomy for Ductal Adenocarcinoma (DIPLOMA): A Pan-European Propensity Score Matched Study.
van Hilst J; de Rooij T; Klompmaker S; Rawashdeh M; Aleotti F; Al-Sarireh B; Alseidi A; Ateeb Z; Balzano G; Berrevoet F; Björnsson B; Boggi U; Busch OR; Butturini G; Casadei R; Del Chiaro M; Chikhladze S; Cipriani F; van Dam R; Damoli I; van Dieren S; Dokmak S; Edwin B; van Eijck C; Fabre JM; Falconi M; Farges O; Fernández-Cruz L; Forgione A; Frigerio I; Fuks D; Gavazzi F; Gayet B; Giardino A; Groot Koerkamp B; Hackert T; Hassenpflug M; Kabir I; Keck T; Khatkov I; Kusar M; Lombardo C; Marchegiani G; Marshall R; Menon KV; Montorsi M; Orville M; de Pastena M; Pietrabissa A; Poves I; Primrose J; Pugliese R; Ricci C; Roberts K; Røsok B; Sahakyan MA; Sánchez-Cabús S; Sandström P; Scovel L; Solaini L; Soonawalla Z; Souche FR; Sutcliffe RP; Tiberio GA; Tomazic A; Troisi R; Wellner U; White S; Wittel UA; Zerbi A; Bassi C; Besselink MG; Abu Hilal M;
Ann Surg; 2019 Jan; 269(1):10-17. PubMed ID: 29099399
[TBL] [Abstract][Full Text] [Related]
18. Impact of neoadjuvant therapy on postoperative outcomes after pancreaticoduodenectomy.
Cools KS; Sanoff HK; Kim HJ; Yeh JJ; Stitzenberg KB
J Surg Oncol; 2018 Sep; 118(3):455-462. PubMed ID: 30114330
[TBL] [Abstract][Full Text] [Related]
19. Short- and mid-term outcomes of robotic versus laparoscopic distal pancreatosplenectomy for pancreatic ductal adenocarcinoma: A retrospective propensity score-matched study.
Qu L; Zhiming Z; Xianglong T; Yuanxing G; Yong X; Rong L; Yee LW
Int J Surg; 2018 Jul; 55():81-86. PubMed ID: 29802919
[TBL] [Abstract][Full Text] [Related]
20. Association of Adjuvant Radiotherapy With Survival After Margin-negative Resection of Pancreatic Ductal Adenocarcinoma: A Propensity-matched National Cancer Database (NCDB) Analysis.
Kamarajah SK; Sonnenday CJ; Cho CS; Frankel TL; Bednar F; Lawrence TS; Nathan H
Ann Surg; 2021 Mar; 273(3):587-594. PubMed ID: 30817352
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
